Small-cell Lung Cancer
Conditions
Interventions
Western medicine treatment group:standard treatment of chemotherapy (EP or EC regimen) for 4–6 cycles, chest irradiation, and prophylactic cranial irradiation according to the 2013 edition of the NCCN
TCM and Western medicine combination treatment group:administered with oral TCM decoction after the end of the first-line chemoradiotherapy by Western medicine
Sponsors
Guang'anmen Hospital, China Academy of Chinese Medicine Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) The age ranges from 18 to 75 years. (2) Patients with localized SCLC with clear pathological diagnosis, following NCCN clinical guidelines, and receiving standardized treatment such as chest radiotherapy, chemotherapy, or prophylactic brain irradiation. (3) Survival time > 3 months. (4) The integrated Chinese and Western medicine treatment group received TCM treatment =6 months.
Exclusion criteria
Exclusion criteria: (1) complicated with serious diseases of heart, liver, kidney and hematopoietic system. (2) other types of primary malignancy. (3) pregnant women, mental patients and patients suffering from other malignant tumors. (4) Patients who have participated in clinical trials of new drugs. (5) Absence of basic information.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression-Free Survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| overall survival; | — |
Countries
China
Contacts
Public ContactLI CONGHUANG
Outcome results
None listed